Skip to content

Home
About Us
Log In

News
- All News
- Finance
- Treatment
- People
- Research
Videos
Treatments
Clinical Trials
Access Programs
- About Access Programs
Diseases
Events
Networks
Research

Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field

Email Marketing Services by Benchmark

Generate RSS

Select number of items

Home
/
First-Line

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Treatments

Flunarizine hydrochloride
Everolimus
Eribulin mesylate
Dexamethasone phosphate
Dantrolene sodium

More Treatments

Events

The European Academy of Allergy and Clinical Immunology Congress (EAAC
The 18th World Congress of the International Society of Physical and R
The 33rd European Meeting on Hypertension and Cardiovascular Renal Pro
The ESMO Gastrointestinal Cancers Congress 2024 will take place in Mun
The American Transplant Congress (ATC 2024) will take place in Philade

Access Programs

Jonsson Comprehensive Cancer Center – Progressive Metastatic Cas
Massachusetts General Hospital – Healthy Naturally Cycling Women
Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal
Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell L
Kite, A Gilead Company – Relapsed/Refractory Transformed Follicu

More Access Programs

Clinical Trials

Wet Cupping Therapy in Ankylosing Spondylitis
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemi
Autoimmune Hepatitis Cohort in China
Cold Agglutinin Disease Real World Evidence Registry
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube

More Clinical Trials

Videos

Rare Conversations: Sheri & Stephanie
Rare Conversations: Kendra & Preston
Overview on Understanding Mitochondria?
Sandra’s Journey in ASMD (Adult Patient)
Patient Caregiver’s Journey in ASMD

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

Your Name (required)

Your Email (required)

Your Message

Copyright © 2024 CheckOrphan.

Developed by:

Developed by: WebOptimalSolutions Powered by: